Daphne M. Hotho

Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV

Jean‐François Bergmann, Joep de Bruijne, Daphne M. Hotho et al. · Alimentary Pharmacology & Therapeutics · 2011 · 52 citations · Full text

Potent Immune Activation in Chronic Hepatitis C Patients upon Administration of An Oral Inducer of Endogenous Interferons that Acts via Toll-Like Receptor 7

André Boonstra, Bisheng Liu, Zwier M. A. Groothuismink et al. · Antiviral Therapy · 2011 · 26 citations · Full text

Unexplained Hyponatremia: Seek and You Will Find

Ewout J. Hoorn, Daphne M. Hotho, Robert Jan Hassing et al. · Nephron Physiology · 2011 · 16 citations

Sustained virologic response after therapy with the <scp>HCV</scp> protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long‐term follow‐up

Daphne M. Hotho, Joep de Bruijne, Michelle Spaan et al. · Journal of Viral Hepatitis · 2013 · 12 citations · Full text

Pharmacokinetics and Antiviral Activity of Phx1766, a Novel HCV Protease Inhibitor, Using An Accelerated Phase I Study Design

Daphne M. Hotho, Joep de Bruijne, A. Marie O'Farrell et al. · Antiviral Therapy · 2011 · 11 citations · Full text